Filing Details
- Accession Number:
- 0001125345-18-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-07 18:46:39
- Reporting Period:
- 2018-03-05
- Accepted Time:
- 2018-03-07 18:46:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587477 | James Karrels | 9704 Medical Center Drive Rockville MD 20850 | Svp, Cfo And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-03-05 | 5,000 | $31.00 | 114,847 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017.
- Owned jointly with reporting person's wife.
Billionaire Hedge Funds
